公司&技術簡介手冊
Executive Summary
2022.07 投資人文件
期刊發表
01_Specific activation of pro-Infliximab enhances selectivity and safety of rheumatoid arthritis therapy_
PLOS Biology 2019 17.6(2019)
02_Ab locks for improving the selectivity and safety of antibody drugs._Journal of Biomedical Science 27.1(2020):1-20
03_Development of a structure-based computational simulation to optimize the blocking efficacy of pro-antibodies
04_Selective activation of pro-anti-IL-1β antibody enhances specificity for autoinflammatory disorder therapy
TOP